iBio (IBIO) to Release Earnings on Friday

iBio (NYSEAMERICAN:IBIO) is expected to be issuing its quarterly earnings data before the market opens on Friday, February 14th. Analysts expect the company to announce earnings of ($0.45) per share for the quarter.

iBio Stock Performance

NYSEAMERICAN IBIO opened at $3.68 on Thursday. iBio has a 1 year low of $1.05 and a 1 year high of $4.98. The company has a debt-to-equity ratio of 0.04, a quick ratio of 0.91 and a current ratio of 0.91.

iBio Company Profile

iBio, Inc, a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases. The company’s technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optimizing technology; and AI epitope steering technology that guides antibodies against the desired regions of the target protein.